Concord Biotech (BOM:543960) Marketable Securities : ₹2,950 Mil (As of Mar. 2024)

View and export this data going back to 2023. Start your Free Trial

What is Concord Biotech Marketable Securities?

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Concord Biotech's Marketable Securities for the quarter that ended in Mar. 2024 was ₹2,950 Mil.

Concord Biotech's annual Marketable Securities increased from Mar. 2022 (₹1,611 Mil) to Mar. 2023 (₹1,682 Mil) and increased from Mar. 2023 (₹1,682 Mil) to Mar. 2024 (₹2,950 Mil).

Concord Biotech Marketable Securities Historical Data

The historical data trend for Concord Biotech's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Concord Biotech Marketable Securities Chart

Concord Biotech Annual Data

Trend

Mar20

Mar21

Mar22

Mar23

Mar24

Marketable Securities

1,983.54

1,960.66

1,611.08

1,682.49

2,950.33

Concord Biotech Semi-Annual Data
	Mar20	Mar21	Mar22	Sep22	Mar23	Sep23	Mar24
Marketable Securities	Get a 7-Day Free Trial			1,611.08	-	1,682.49	2,454.86	2,950.33

Concord Biotech Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Concord Biotech (BOM:543960) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

Concord Biotech Marketable Securities Related Terms

Thank you for viewing the detailed overview of Concord Biotech's Marketable Securities provided by GuruFocus.com. Please click on the following links to see related term pages.

Concord Biotech (BOM:543960) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Concord Biotech Ltd (BOM:543960) » Definitions » Marketable Securities

Comparable Companies

Traded in Other Exchanges

CONCORDBIO:India

Address

Iscon Cross Road, S.G. Highway, 16th floor, B-Wing, Mondeal Heights, Ahmedabad, GJ, IND, 380015

Website

https://www.concordbiotech.com

Concord Biotech Ltd is a Research & development-driven biopharma Company that manufactures Active Pharmaceutical Ingredients (API) through fermentation & semi-synthetic process and finished formulations.

Concord Biotech (BOM:543960) Headlines

No Headlines